MedicalConspiracies- ALL Americans Will Get Two Experimental Vaccinations, Says U.S. Government

-------- Original Message --------




*[H7N9] ALL Americans Will Get Two Experimental Vaccinations, Says U.S.
Government *

WATCH THE VIDEO: {{ http://www.youtube.com/watch?v=hBGVRuYz7_0#t=13 }}

[There will be a risk of narcolepsy from the vaccines. By the way, in
case you don't know how the "vaccine con" works, here's the story. They
first find evidence of a small amount of a disease or bacteria in the
population and report it widely, saying it may be an epidemic, even when
it might be easily stopped. They tell everyone they need vaccines. The
VACCINES now either spread the disease further, or make people MORE
susceptible to the disease. Now the disease reaches millions, but many
live, and they tell you in the end that the vaccines saved them, when in
fact, the vaccines were used to create the pandemic.]

*Published on **Sep 9, 2013***

http://pissinontheroses.blogspot.com/...
<http://pissinontheroses.blogspot.com/2013/09/alert-all-300-million-american-citizens.html>
(c)2013 www.POTRBLOG.com
The Office of the Assistance Secretary for Preparedness and Response
[ASPR] just released a Medical Counter Measures (MCM) document in which
they indicate they are planning to give all 300 million Americans TWO
experimental adjuvant laced H7N9 vaccinations.

Links available at
http://pissinontheroses.blogspot.com/...
<http://pissinontheroses.blogspot.com/2013/09/alert-all-300-million-american-citizens.html>

mailbox:///C:/Users/User/AppData/Roaming/Thunderbird/Profiles/k7pjeoc2.default/Mail/pop3.xtra.co.nz/Inbox?number=805510935&part=1.2&filename=image001.png

mailbox:///C:/Users/User/AppData/Roaming/Thunderbird/Profiles/k7pjeoc2.default/Mail/pop3.xtra.co.nz/Inbox?number=805510935&part=1.3&filename=image002.png


Enhanced Evaluation of Risk of Narcolepsy Associated with Pandemrix
and Arepanrix and MF59-adjvanted H1N1 vaccines

Solicitation Number: SNR60110

Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention
Location: Procurement and Grants Office (Atlanta)

Solicitation Number:

SNR60110

Notice Type:

Presolicitation

Synopsis:

Added: May 23, 2013 9:24 am

CONTRACTING OFFICE ADDRESS:Department of Health and Human Services,
Center for Disease Control and Prevention, Procurement and Grants
Office, Acquisition and Assistance Branch 1, 2920 Brandywine Road, MS
K-14, Atlanta, GA 30341-5539

NOTICE OF INTENT TO SOLE SOURCE: The Centers for Disease Control and
Prevention (CDC) announces its intention to revise the scope of work for
Contract No. 200-2012-53425 currently awarded to The Brighton
Collaboration Foundation, Basel, Che, BS 4056. The Brighton
Collaboration study will be expanded to include countries that used
MF59-adjuvanted H1N1 studies.

The European CDC has coordinated a multi-country study through the
Vaccine Adverse Event Surveillance and Communication [VAESCO]
Consortium) of Pandemrix and narcolepsy, which is being conducted by the
Brighton Collaboration. The purpose of this project is to build upon the
multi-country European CDC coordinated study (through VAESCO) on
evaluation of risk of narcolepsy associated with Pandemrix, an
adjuvanted monovalent influenza A (H1N1) vaccine that was widely used in
Europe during the H1N1 influenza pandemic. This project also evaluates
risk of narcolepsy associated with Arepanrix.

In preparation for a possible large scale national H7N9 influenza
vaccination program, CDC is considering using the two oil-in-water
emulsion adjuvants in its stockpile (AS03 and MF59) with an H7N9
vaccine. CDC's current study with the Brighton Collaboration is focused
on assessing the risk of narcolepsy following ASO3-adjuvanted H1N1
vaccines. CDC plans to expand the current Brighton Collaboration study
to (1) include countries that used the MF59-adjuvanted H1N1 vaccines
with large linked databases or other appropriate data sources that have
data on adolescent and young adult populations to facilitate
identification of narcolepsy cases and controls for participation in the
study expansion and (2) assess whether there is a risk of narcolepsy
following MF59-adjuvanted H1N1 vaccines.

Countries with large linked databases that have data on adolescent
populations (those at increased risk of narcolepsy) will be given
priority to participate. This will facilitate the conduct of nested
case-control studies, making the investigation more efficient and less
costly. Findings from this work will result in a final report to the
CDC, the European CDC (ECDC) and to the ministries of health in other
participating countries. In addition, the contractor may submit findings
to peer reviewed journal(s).
The anticipated date to modify Contract #200-2012-53425 will be
7/1/2013. The Brighton Collaboration Foundation has been the primary
contractor for the study since the start of the project and it is
uniquely situated to support the Government's goal of expanding its
current study and to enroll other countries to gain a better
understanding of the risk of narcolepsy following MF59-adjuvanted H1N1
vaccines. The Brighton Collaboration Foundation is the only source
available to rapidly implement the expansion of the ongoing study to
address MF59-adjuvanted H1N1 vaccines within the critical time-frame
deemed necessary. CDC intends to negotiate this requirement under the
authority of FAR 6.302-1(a)(2) This notice of intent is not a request
for competitive proposals. A determination to compete this procurement
based on a response to this notice is solely within the discretion of
the Government. Interested parties who believe they possess the
capabilities to satisfy this requirement should submit a capability
statement demonstrating their abilities to meet this requirement. All
responses shall be received by June 6, 2013, 2PM Eastern Standard Time
(EST). All responses must be in writing and can be sent via email to
iom2@cdc.gov . No phone calls will be accepted.

Contracting Office Address:

2920 Brandywine Road, Room 3000
Atlanta, Georgia 30341-4146

Place of Performance:

SPITALSTRASSE 33, BASEL CHE, 4056
Non-U.S.
Switzerland

{{
https://www.fbo.gov/index?s=opportunity&mode=form&id=fbceddd0d00cf479dcd6efab4ce849e6&tab=core&_cview=0
}}



--
--
To subscribe: MedicalConspiracies-subscribe@googlegroups.com
Alternative Medicine info: http://www.elementsofhealth.webs.com/

"ClayAdvantage" The Gift of Health http://ClayAdvantage.com/
Holistic Store: http://www.holisticenergystore.com/

Information here in is for educational purpose only; it may be news related,
speculation or opinion. Consult with a qualified MD before deciding on any course of treatment, especially for serious or life-threatening illnesses.
FDA and FTC have not evaluated or endorsed any message or product from this group. http://www.law.cornell.edu/uscode/17/107.shtml

---
You received this message because you are subscribed to the Google Groups "MedicalConspiracies" group.
To unsubscribe from this group and stop receiving emails from it, send an email to medicalconspiracies+unsubscribe@googlegroups.com.
For more options, visit https://groups.google.com/groups/opt_out.